Mohamed Ahmed, Shehada Sharaf-Eldin, Van Brakel Lena, Ruhparwar Arjang, Hochreiter Marcel, Berger Marc Moritz, Brenner Thorsten, Haddad Ali
Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany.
Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Center, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.
J Clin Med. 2022 Jul 22;11(15):4274. doi: 10.3390/jcm11154274.
Background: Robotic-assisted surgery is gaining more adaption in different surgical specialties. The number of patients undergoing robotic-assisted thymectomy is continuously increasing. Such procedures are accompanied by new challenges for anesthesiologists. We are presenting our primary anesthesiologic experience in such patients. Methods: This is a retrospective single center study, evaluating 28 patients who presented with thymoma or myasthenia gravis (MG) and undergone minimal invasive robotic-assisted thoracic thymectomy between 01/2020−01/2022. We present our fast-track anesthesia management as a component of the enhanced recovery program and its primary results. Results: Mean patient’s age was 46.8 ± 18.1 years, and the mean height was 173.1 ± 9.3 cm. Two-thirds of patients were female (n = 18, 64.3%). The preoperative mean forced expiratory volume in the first second (FEV1) was 3.8 ± 0.7 L, forced vital capacity (FVC) was 4.7 ± 1.1 L, and the FEV1/FVC ratio was 80.4 ± 5.3%. After the creation of capnomediastinum, central venous pressure and airway pressure have been significantly increased from the baseline values (16.5 ± 4.9 mmHg versus 13.4 ± 5.1 mmHg, p < 0.001 and 23.4 ± 4.4 cmH2O versus 19.3 ± 3.9 cmH2O, p < 0.001, respectively). Most patients (n = 21, 75%) developed transient arrhythmias episodes with hypotension. All patients were extubated at the end of surgery and discharged awake to the recovery room. The first 16 (57.1%) patients were admitted to the intensive care unit and the last 12 patients were only observed in intermediate care. Postoperatively, one patient developed atelectasis and was treated with non-invasive ventilation therapy. Pneumonia or reintubation was not observed. Finally, no significant difference was observed between MG and thymoma patients regarding analgesics consumption or incidence of complications. Conclusions: Robotic-assisted surgery is a rapidly growing technology with increased adoption in different specialties. Fast-track anesthesia is an important factor in an enhanced recovery program and the anesthetist should be familiar with challenges in this kind of operation to achieve optimal results. So far, our anesthetic management of patients undergoing robotic-assisted thymectomy reports safe and feasible procedures.
机器人辅助手术在不同外科专业中越来越多地得到应用。接受机器人辅助胸腺切除术的患者数量持续增加。此类手术给麻醉医生带来了新的挑战。我们在此介绍我们对此类患者的主要麻醉经验。
这是一项回顾性单中心研究,评估了28例患有胸腺瘤或重症肌无力(MG)且在2020年1月至2022年1月期间接受了微创机器人辅助胸腺瘤切除术的患者。我们介绍了作为强化康复计划一部分的快速麻醉管理及其主要结果。
患者平均年龄为46.8±18.1岁,平均身高为173.1±9.3厘米。三分之二的患者为女性(n = 18,64.3%)。术前第一秒用力呼气量(FEV1)平均为3.8±0.7升,用力肺活量(FVC)为4.7±1.1升,FEV1/FVC比值为80.4±5.3%。建立二氧化碳纵隔后,中心静脉压和气道压力较基线值显著升高(分别为16.5±4.9 mmHg对13.4±5.1 mmHg,p < 0.001;23.4±4.4 cmH₂O对19.3±3.9 cmH₂O,p < 0.001)。大多数患者(n = 21,75%)出现伴有低血压的短暂心律失常发作。所有患者均在手术结束时拔管,并清醒地送入恢复室。前16例(57.1%)患者被收入重症监护病房,后12例患者仅在中级护理病房观察。术后,1例患者发生肺不张,接受了无创通气治疗。未观察到肺炎或再次插管情况。最后,在镇痛药使用或并发症发生率方面,MG患者和胸腺瘤患者之间未观察到显著差异。
机器人辅助手术是一项迅速发展的技术,在不同专业中的应用日益增多。快速麻醉是强化康复计划中的一个重要因素,麻醉医生应熟悉此类手术中的挑战以取得最佳效果。到目前为止,我们对接受机器人辅助胸腺切除术患者的麻醉管理报告了安全可行的手术过程。